 | • レポートコード：QYR9ST03047 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の遅発性ジスキネジア（TD）治療市場について調査・分析し、以下の構成でお届け致します。遅発性ジスキネジア（TD）治療の種類別には、バルベナジン、アマンタジン、テトラベナジン、クロナゼパム、その他に、用途別には、病院、クリニック、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別遅発性ジスキネジア（TD）治療売上データ ・地域別遅発性ジスキネジア（TD）治療市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別遅発性ジスキネジア（TD）治療市場規模：バルベナジン、アマンタジン、テトラベナジン、クロナゼパム、その他 ・用途別遅発性ジスキネジア（TD）治療市場規模：病院、クリニック、その他 ・主要メーカーの企業情報：Teva Pharma、Biogen、Johnson & Johnson、GlaxoSmithKline、Neurocrine Biosciences、Pfizer、Novartis、Sanofi、AstraZeneca、Bayer AG ・遅発性ジスキネジア（TD）治療の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Tardive dyskinesia (TD) is a neurological disorder that has the involvement of the involuntary movements. The terms can be described as tardive which means delayed and dyskinesia which means abnormal movement. The symptoms of tardive dyskinesia include finger movement, facial grimacing, jaw swinging, repetitive chewing, continuous blinking of the eyes, tongue thrusting, and others. The global Tardive Dyskinesia (TD) Therapy market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Tardive Dyskinesia (TD) Therapy market based on company, product type, end user and key regions.
This report studies the global market size of Tardive Dyskinesia (TD) Therapy in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Tardive Dyskinesia (TD) Therapy in these regions.
This research report categorizes the global Tardive Dyskinesia (TD) Therapy market by top players/brands, region, type and end user. This report also studies the global Tardive Dyskinesia (TD) Therapy market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Teva Pharma
Biogen
Johnson & Johnson
GlaxoSmithKline
Neurocrine Biosciences
Pfizer
Novartis
Sanofi
AstraZeneca
Bayer AG
Market size by Product
Valbenazine
Amantadine
Tetrabenazine
Clonazepam
Others
Market size by End User
Hospitals
Clinics
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Tardive Dyskinesia (TD) Therapy market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Tardive Dyskinesia (TD) Therapy market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Tardive Dyskinesia (TD) Therapy companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Tardive Dyskinesia (TD) Therapy submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Tardive Dyskinesia (TD) Therapy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Tardive Dyskinesia (TD) Therapy market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Tardive Dyskinesia (TD) Therapy Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Tardive Dyskinesia (TD) Therapy Market Size Growth Rate by Product
1.4.2 Valbenazine
1.4.3 Amantadine
1.4.4 Tetrabenazine
1.4.5 Clonazepam
1.4.6 Others
1.5 Market by End User
1.5.1 Global Tardive Dyskinesia (TD) Therapy Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Tardive Dyskinesia (TD) Therapy Market Size
2.1.1 Global Tardive Dyskinesia (TD) Therapy Revenue 2014-2025
2.1.2 Global Tardive Dyskinesia (TD) Therapy Sales 2014-2025
2.2 Tardive Dyskinesia (TD) Therapy Growth Rate by Regions
2.2.1 Global Tardive Dyskinesia (TD) Therapy Sales by Regions
2.2.2 Global Tardive Dyskinesia (TD) Therapy Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Tardive Dyskinesia (TD) Therapy Sales by Manufacturers
3.1.1 Tardive Dyskinesia (TD) Therapy Sales by Manufacturers
3.1.2 Tardive Dyskinesia (TD) Therapy Sales Market Share by Manufacturers
3.1.3 Global Tardive Dyskinesia (TD) Therapy Market Concentration Ratio (CR5 and HHI)
3.2 Tardive Dyskinesia (TD) Therapy Revenue by Manufacturers
3.2.1 Tardive Dyskinesia (TD) Therapy Revenue by Manufacturers (2014-2019)
3.2.2 Tardive Dyskinesia (TD) Therapy Revenue Share by Manufacturers (2014-2019)
3.3 Tardive Dyskinesia (TD) Therapy Price by Manufacturers
3.4 Tardive Dyskinesia (TD) Therapy Manufacturing Base Distribution, Product Types
3.4.1 Tardive Dyskinesia (TD) Therapy Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Tardive Dyskinesia (TD) Therapy Product Type
3.4.3 Date of International Manufacturers Enter into Tardive Dyskinesia (TD) Therapy Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Tardive Dyskinesia (TD) Therapy Sales by Product
4.2 Global Tardive Dyskinesia (TD) Therapy Revenue by Product
4.3 Tardive Dyskinesia (TD) Therapy Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Tardive Dyskinesia (TD) Therapy Breakdown Data by End User
6 North America
6.1 North America Tardive Dyskinesia (TD) Therapy by Countries
6.1.1 North America Tardive Dyskinesia (TD) Therapy Sales by Countries
6.1.2 North America Tardive Dyskinesia (TD) Therapy Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Tardive Dyskinesia (TD) Therapy by Product
6.3 North America Tardive Dyskinesia (TD) Therapy by End User
7 Europe
7.1 Europe Tardive Dyskinesia (TD) Therapy by Countries
7.1.1 Europe Tardive Dyskinesia (TD) Therapy Sales by Countries
7.1.2 Europe Tardive Dyskinesia (TD) Therapy Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Tardive Dyskinesia (TD) Therapy by Product
7.3 Europe Tardive Dyskinesia (TD) Therapy by End User
8 Asia Pacific
8.1 Asia Pacific Tardive Dyskinesia (TD) Therapy by Countries
8.1.1 Asia Pacific Tardive Dyskinesia (TD) Therapy Sales by Countries
8.1.2 Asia Pacific Tardive Dyskinesia (TD) Therapy Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Tardive Dyskinesia (TD) Therapy by Product
8.3 Asia Pacific Tardive Dyskinesia (TD) Therapy by End User
9 Central & South America
9.1 Central & South America Tardive Dyskinesia (TD) Therapy by Countries
9.1.1 Central & South America Tardive Dyskinesia (TD) Therapy Sales by Countries
9.1.2 Central & South America Tardive Dyskinesia (TD) Therapy Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Tardive Dyskinesia (TD) Therapy by Product
9.3 Central & South America Tardive Dyskinesia (TD) Therapy by End User
10 Middle East and Africa
10.1 Middle East and Africa Tardive Dyskinesia (TD) Therapy by Countries
10.1.1 Middle East and Africa Tardive Dyskinesia (TD) Therapy Sales by Countries
10.1.2 Middle East and Africa Tardive Dyskinesia (TD) Therapy Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Tardive Dyskinesia (TD) Therapy by Product
10.3 Middle East and Africa Tardive Dyskinesia (TD) Therapy by End User
11 Company Profiles
11.1 Teva Pharma
11.1.1 Teva Pharma Company Details
11.1.2 Company Business Overview
11.1.3 Teva Pharma Tardive Dyskinesia (TD) Therapy Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Teva Pharma Tardive Dyskinesia (TD) Therapy Products Offered
11.1.5 Teva Pharma Recent Development
11.2 Biogen
11.2.1 Biogen Company Details
11.2.2 Company Business Overview
11.2.3 Biogen Tardive Dyskinesia (TD) Therapy Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Biogen Tardive Dyskinesia (TD) Therapy Products Offered
11.2.5 Biogen Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Company Business Overview
11.3.3 Johnson & Johnson Tardive Dyskinesia (TD) Therapy Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Johnson & Johnson Tardive Dyskinesia (TD) Therapy Products Offered
11.3.5 Johnson & Johnson Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 Company Business Overview
11.4.3 GlaxoSmithKline Tardive Dyskinesia (TD) Therapy Sales, Revenue and Gross Margin (2014-2019)
11.4.4 GlaxoSmithKline Tardive Dyskinesia (TD) Therapy Products Offered
11.4.5 GlaxoSmithKline Recent Development
11.5 Neurocrine Biosciences
11.5.1 Neurocrine Biosciences Company Details
11.5.2 Company Business Overview
11.5.3 Neurocrine Biosciences Tardive Dyskinesia (TD) Therapy Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Neurocrine Biosciences Tardive Dyskinesia (TD) Therapy Products Offered
11.5.5 Neurocrine Biosciences Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Company Business Overview
11.6.3 Pfizer Tardive Dyskinesia (TD) Therapy Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Pfizer Tardive Dyskinesia (TD) Therapy Products Offered
11.6.5 Pfizer Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Company Business Overview
11.7.3 Novartis Tardive Dyskinesia (TD) Therapy Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Novartis Tardive Dyskinesia (TD) Therapy Products Offered
11.7.5 Novartis Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Company Business Overview
11.8.3 Sanofi Tardive Dyskinesia (TD) Therapy Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Sanofi Tardive Dyskinesia (TD) Therapy Products Offered
11.8.5 Sanofi Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 Company Business Overview
11.9.3 AstraZeneca Tardive Dyskinesia (TD) Therapy Sales, Revenue and Gross Margin (2014-2019)
11.9.4 AstraZeneca Tardive Dyskinesia (TD) Therapy Products Offered
11.9.5 AstraZeneca Recent Development
11.10 Bayer AG
11.10.1 Bayer AG Company Details
11.10.2 Company Business Overview
11.10.3 Bayer AG Tardive Dyskinesia (TD) Therapy Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Bayer AG Tardive Dyskinesia (TD) Therapy Products Offered
11.10.5 Bayer AG Recent Development
12 Future Forecast
12.1 Tardive Dyskinesia (TD) Therapy Market Forecast by Regions
12.1.1 Global Tardive Dyskinesia (TD) Therapy Sales Forecast by Regions 2019-2025
12.1.2 Global Tardive Dyskinesia (TD) Therapy Revenue Forecast by Regions 2019-2025
12.2 Tardive Dyskinesia (TD) Therapy Market Forecast by Product
12.2.1 Global Tardive Dyskinesia (TD) Therapy Sales Forecast by Product 2019-2025
12.2.2 Global Tardive Dyskinesia (TD) Therapy Revenue Forecast by Product 2019-2025
12.3 Tardive Dyskinesia (TD) Therapy Market Forecast by End User
12.4 North America Tardive Dyskinesia (TD) Therapy Forecast
12.5 Europe Tardive Dyskinesia (TD) Therapy Forecast
12.6 Asia Pacific Tardive Dyskinesia (TD) Therapy Forecast
12.7 Central & South America Tardive Dyskinesia (TD) Therapy Forecast
12.8 Middle East and Africa Tardive Dyskinesia (TD) Therapy Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Tardive Dyskinesia (TD) Therapy Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Tardive Dyskinesia (TD) Therapy Product Picture
Table Tardive Dyskinesia (TD) Therapy Market Segments
Table Key Manufacturers Tardive Dyskinesia (TD) Therapy Covered
Table Global Tardive Dyskinesia (TD) Therapy Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Tardive Dyskinesia (TD) Therapy Sales Market Share by Product 2014-2025
Figure Valbenazine Product Picture
Table Major Manufacturers of Valbenazine
Figure Amantadine Product Picture
Table Major Manufacturers of Amantadine
Figure Tetrabenazine Product Picture
Table Major Manufacturers of Tetrabenazine
Figure Clonazepam Product Picture
Table Major Manufacturers of Clonazepam
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Tardive Dyskinesia (TD) Therapy Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospitals
Figure Clinics
Figure Others
Figure Tardive Dyskinesia (TD) Therapy Report Years Considered
Figure Global Tardive Dyskinesia (TD) Therapy Market Size 2014-2025 (Million US$)
Figure Global Tardive Dyskinesia (TD) Therapy Sales 2014-2025 (K Units)
Table Global Tardive Dyskinesia (TD) Therapy Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Tardive Dyskinesia (TD) Therapy Sales by Regions 2014-2019 (K Units)
Table Global Tardive Dyskinesia (TD) Therapy Sales Market Share by Regions 2014-2019
Figure Global Tardive Dyskinesia (TD) Therapy Sales Market Share by Regions 2014-2019
Figure 2018 Global Tardive Dyskinesia (TD) Therapy Sales Market Share by Regions
Table Global Tardive Dyskinesia (TD) Therapy Revenue by Regions 2014-2019 (Million US$)
Table Global Tardive Dyskinesia (TD) Therapy Revenue Market Share by Regions 2014-2019
Figure Global Tardive Dyskinesia (TD) Therapy Revenue Market Share by Regions 2014-2019
Figure 2018 Global Tardive Dyskinesia (TD) Therapy Revenue Market Share by Regions
Table Global Tardive Dyskinesia (TD) Therapy Sales by Manufacturers (2014-2019) (K Units)
Table Global Tardive Dyskinesia (TD) Therapy Sales Share by Manufacturers (2014-2019)
Figure Global Tardive Dyskinesia (TD) Therapy Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Tardive Dyskinesia (TD) Therapy Revenue by Manufacturers (2014-2019) (Million USD)
Table Tardive Dyskinesia (TD) Therapy Revenue Share by Manufacturers (2014-2019)
Figure Tardive Dyskinesia (TD) Therapy Value Share by Manufacturers in 2018
Table Key Manufacturers Tardive Dyskinesia (TD) Therapy Price (2014-2019) (USD/Unit)
Table Tardive Dyskinesia (TD) Therapy Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Tardive Dyskinesia (TD) Therapy Product Type
Table Date of International Manufacturers Enter into Tardive Dyskinesia (TD) Therapy Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Tardive Dyskinesia (TD) Therapy Sales by Product (2014-2019) (K Units)
Table Global Tardive Dyskinesia (TD) Therapy Sales Share by Product (2014-2019)
Figure Global Tardive Dyskinesia (TD) Therapy Sales Market Share by Product (2014-2019)
Figure Global Tardive Dyskinesia (TD) Therapy Sales Market Share by Product in 2018
Table Global Tardive Dyskinesia (TD) Therapy Revenue by Product (2014-2019) (Million US$)
Table Global Tardive Dyskinesia (TD) Therapy Revenue Share by Product (2014-2019)
Figure Global Tardive Dyskinesia (TD) Therapy Revenue Market Share by Product (2014-2019)
Figure Global Tardive Dyskinesia (TD) Therapy Revenue Market Share by Product in 2018
Table Tardive Dyskinesia (TD) Therapy Price by Product 2014-2019 (USD/Unit)
Table Global Tardive Dyskinesia (TD) Therapy Sales by End User (2014-2019) (K Units)
Table Global Tardive Dyskinesia (TD) Therapy Sales Share by End User (2014-2019)
Figure Global Sales Tardive Dyskinesia (TD) Therapy Market Share by End User (2014-2019)
Figure Global Sales Tardive Dyskinesia (TD) Therapy Market Share by End User in 2018
Figure North America Tardive Dyskinesia (TD) Therapy Sales Growth Rate 2014-2019 (K Units)
Figure North America Tardive Dyskinesia (TD) Therapy Revenue Growth Rate 2014-2019 (Million US$)
Table North America Tardive Dyskinesia (TD) Therapy Sales by Countries (2014-2019) (K Units)
Table North America Tardive Dyskinesia (TD) Therapy Sales Market Share by Countries (2014-2019)
Figure 2018 North America Tardive Dyskinesia (TD) Therapy Sales Market Share by Countries
Table North America Tardive Dyskinesia (TD) Therapy Revenue by Countries (2014-2019) (Million US$)
Table North America Tardive Dyskinesia (TD) Therapy Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Tardive Dyskinesia (TD) Therapy Revenue Market Share by Countries
Figure United States Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2014-2019) (K Units)
Figure United States Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Canada Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2014-2019) (Million US$)
Table North America Tardive Dyskinesia (TD) Therapy Sales by Product (2014-2019) (K Units)
Table North America Tardive Dyskinesia (TD) Therapy Sales Market Share by Product (2014-2019)
Figure 2018 North America Tardive Dyskinesia (TD) Therapy Market Share by Product
Table North America Tardive Dyskinesia (TD) Therapy Sales by End User (2014-2019) (K Units)
Table North America Tardive Dyskinesia (TD) Therapy Sales Market Share by End User (2014-2019)
Figure 2018 North America Tardive Dyskinesia (TD) Therapy Market Share by End User
Figure Europe Tardive Dyskinesia (TD) Therapy Sales Growth Rate 2014-2019 (K Units)
Figure Europe Tardive Dyskinesia (TD) Therapy Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Tardive Dyskinesia (TD) Therapy Sales by Countries (2014-2019) (K Units)
Table Europe Tardive Dyskinesia (TD) Therapy Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Tardive Dyskinesia (TD) Therapy Sales Market Share by Countries
Table Europe Tardive Dyskinesia (TD) Therapy Revenue by Countries (2014-2019) (Million US$)
Table Europe Tardive Dyskinesia (TD) Therapy Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Tardive Dyskinesia (TD) Therapy Revenue Market Share by Countries
Figure Germany Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Germany Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure France Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2014-2019) (K Units)
Figure France Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2014-2019) (K Units)
Figure UK Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Italy Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Russia Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Tardive Dyskinesia (TD) Therapy Sales by Product (2014-2019) (K Units)
Table Europe Tardive Dyskinesia (TD) Therapy Sales Market Share by Product (2014-2019)
Figure 2018 Europe Tardive Dyskinesia (TD) Therapy Market Share by Product
Table Europe Tardive Dyskinesia (TD) Therapy Sales by End User (2014-2019) (K Units)
Table Europe Tardive Dyskinesia (TD) Therapy Sales Market Share by End User (2014-2019)
Figure 2018 Europe Tardive Dyskinesia (TD) Therapy Market Share by End User
Figure Asia Pacific Tardive Dyskinesia (TD) Therapy Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Tardive Dyskinesia (TD) Therapy Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Tardive Dyskinesia (TD) Therapy Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Tardive Dyskinesia (TD) Therapy Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Tardive Dyskinesia (TD) Therapy Sales Market Share by Countries
Table Asia Pacific Tardive Dyskinesia (TD) Therapy Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Tardive Dyskinesia (TD) Therapy Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Tardive Dyskinesia (TD) Therapy Revenue Market Share by Countries
Figure China Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2014-2019) (K Units)
Figure China Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Japan Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Korea Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure India Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2014-2019) (K Units)
Figure India Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Australia Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Tardive Dyskinesia (TD) Therapy Sales by Product (2014-2019) (K Units)
Table Asia Pacific Tardive Dyskinesia (TD) Therapy Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Tardive Dyskinesia (TD) Therapy Market Share by Product
Table Asia Pacific Tardive Dyskinesia (TD) Therapy Sales by End User (2014-2019) (K Units)
Table Asia Pacific Tardive Dyskinesia (TD) Therapy Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Tardive Dyskinesia (TD) Therapy Market Share by End User
Figure Central & South America Tardive Dyskinesia (TD) Therapy Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Tardive Dyskinesia (TD) Therapy Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Tardive Dyskinesia (TD) Therapy Sales by Countries (2014-2019) (K Units)
Table Central & South America Tardive Dyskinesia (TD) Therapy Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Tardive Dyskinesia (TD) Therapy Sales Market Share by Countries
Table Central & South America Tardive Dyskinesia (TD) Therapy Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Tardive Dyskinesia (TD) Therapy Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Tardive Dyskinesia (TD) Therapy Revenue Market Share by Countries
Figure Brazil Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Tardive Dyskinesia (TD) Therapy Sales by Product (2014-2019) (K Units)
Table Central & South America Tardive Dyskinesia (TD) Therapy Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Tardive Dyskinesia (TD) Therapy Market Share by Product
Table Central & South America Tardive Dyskinesia (TD) Therapy Sales by End User (2014-2019) (K Units)
Table Central & South America Tardive Dyskinesia (TD) Therapy Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Tardive Dyskinesia (TD) Therapy Market Share by End User
Figure Middle East and Africa Tardive Dyskinesia (TD) Therapy Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Tardive Dyskinesia (TD) Therapy Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Tardive Dyskinesia (TD) Therapy Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Tardive Dyskinesia (TD) Therapy Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Tardive Dyskinesia (TD) Therapy Sales Market Share by Countries
Table Middle East and Africa Tardive Dyskinesia (TD) Therapy Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Tardive Dyskinesia (TD) Therapy Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Tardive Dyskinesia (TD) Therapy Revenue Market Share by Countries
Figure GCC Countries Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Tardive Dyskinesia (TD) Therapy Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Tardive Dyskinesia (TD) Therapy Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Tardive Dyskinesia (TD) Therapy Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Tardive Dyskinesia (TD) Therapy Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Tardive Dyskinesia (TD) Therapy Market Share by Product
Table Middle East and Africa Tardive Dyskinesia (TD) Therapy Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Tardive Dyskinesia (TD) Therapy Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Tardive Dyskinesia (TD) Therapy Market Share by End User
Table Teva Pharma Company Details
Table Teva Pharma Tardive Dyskinesia (TD) Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Teva Pharma Recent Development
Table Biogen Company Details
Table Biogen Tardive Dyskinesia (TD) Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Biogen Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Tardive Dyskinesia (TD) Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson & Johnson Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Tardive Dyskinesia (TD) Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Recent Development
Table Neurocrine Biosciences Company Details
Table Neurocrine Biosciences Tardive Dyskinesia (TD) Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Neurocrine Biosciences Recent Development
Table Pfizer Company Details
Table Pfizer Tardive Dyskinesia (TD) Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Novartis Company Details
Table Novartis Tardive Dyskinesia (TD) Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Recent Development
Table Sanofi Company Details
Table Sanofi Tardive Dyskinesia (TD) Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Tardive Dyskinesia (TD) Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Recent Development
Table Bayer AG Company Details
Table Bayer AG Tardive Dyskinesia (TD) Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer AG Recent Development
Table Global Tardive Dyskinesia (TD) Therapy Sales Forecast by Regions 2019-2025 (K Units)
Table Global Tardive Dyskinesia (TD) Therapy Sales Market Share Forecast by Regions 2019-2025
Table Global Tardive Dyskinesia (TD) Therapy Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Tardive Dyskinesia (TD) Therapy Revenue Market Share Forecast by Regions 2019-2025
Table Global Tardive Dyskinesia (TD) Therapy Sales Forecast by Product 2019-2025 (K Units)
Table Global Tardive Dyskinesia (TD) Therapy Sales Market Share Forecast by Product 2019-2025
Table Global Tardive Dyskinesia (TD) Therapy Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Tardive Dyskinesia (TD) Therapy Revenue Market Share Forecast by Product 2019-2025
Table Global Tardive Dyskinesia (TD) Therapy Sales Forecast by End User 2019-2025 (K Units)
Table Global Tardive Dyskinesia (TD) Therapy Sales Market Share Forecast by End User 2019-2025
Figure North America Tardive Dyskinesia (TD) Therapy Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Tardive Dyskinesia (TD) Therapy Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Tardive Dyskinesia (TD) Therapy Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Tardive Dyskinesia (TD) Therapy Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Tardive Dyskinesia (TD) Therapy Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Tardive Dyskinesia (TD) Therapy Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Tardive Dyskinesia (TD) Therapy Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Tardive Dyskinesia (TD) Therapy Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Tardive Dyskinesia (TD) Therapy Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Tardive Dyskinesia (TD) Therapy Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Tardive Dyskinesia (TD) Therapy Value Chain
Table Tardive Dyskinesia (TD) Therapy Customers List
Table Tardive Dyskinesia (TD) Therapy Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
遅発性ジスキネジアの世界市場：市場規模・現状・予測 Tardive Dyskinesia (TD) market is estimated to post significant growth in coming years, owing to rising schizophrenia patients, increasing bipolar patients, growing antipsychotic prescription and increasing incidence of neurological disorders.The key factors driving the growth of the Tardive dyskine…- 静脈内レーザー療法の世界市場：インサイト・予測 Endovenous laser treatment (ELT) is a minimally invasive ultrasound-guided technique used for treating varicose veins using laser energy commonly performed by a phlebologist, interventional radiologistor vascular surgeon.Endovenous laser systems segment is estimated to record absolute $ opportunity …
- 全身感染療法の世界市場：インサイト・予測 Systemic infection is a pathogenic infection that gets affected throughout the body. It can consist of viral, bacterial, or fungal infections. Systemic infection affects the person’s bloodstream and gradually spreads to the whole body. The systemic infections can range from common ones such as flu, …
- レーザー治療キャップの世界市場：インサイト・予測 Laser Therapy Cap is a drug-free and non-invasive treatment method which provides relief from chronic, acute hair loss and also helps in improving the blood circulation. Therapeutic for hair loss using laser caps is considered as an alternative to surgical treatment and drug therapy.Laser Cap is sup…
- レーザー治療装置の世界市場：インサイト・予測 Medical lasers are sources of focussed light with precision and are used to treat different types of tissues found in the body. Due to the properties of laser light, which has a specific wavelength in a narrow beam, it creates a kind of high intensity light. Due to the cutting-edge innovations in th…